Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Ludwig Institute for Cancer Research receives NHMRC's largest 2009 grant

Abstract:
$20 million to tackle most common cancer in Australia

Ludwig Institute for Cancer Research receives NHMRC's largest 2009 grant

Australia | Posted on February 5th, 2008

Australia's National Health & Medical Research Council (NHMRC) has awarded its largest grant for 2009 to the Ludwig Institute for Cancer Research (LICR) in Melbourne.

This grant will allow the LICR to bring together 18 key investigators from five Melbourne institutions to develop new ways of detecting and treating cancers of the colon and rectum, the most common form of cancer in Australia. More than 12,000 people are diagnosed each year with colon cancer and more than one third of those people - 4,000 Australians - will die as a result of this disease.

The Melbourne group, which combines laboratory and clinical investigators, will tackle five key projects relating to the discovery and analysis of the genetic causes of colon cancer, the development of biomarkers for the early detection of colon cancer and the continuing development of therapies targeted specifically to colon cancer cells, including antibody- and nanoparticle-mediated delivery of therapeutics.

According to LICR Melbourne Branch Director, Professor Tony Burgess, the principal investigator of the NHMRC grant, this large award to a collaborative group is consistent with the changing paradigm of cancer research. "Over the past decade or so, we've moved away from small groups working on individual aspects of a research problem, to larger collaborative groups in which researchers from multiple disciplines can combine their knowledge and expertise. To progress our efforts to combat colon cancer, we needed to bring together top-quality scientific and clinical minds. This grant creates the collaborative opportunity to improve outcomes for colon cancer patients".

####

About Ludwig Institute for Cancer Research
The LICR Melbourne Branch, located at the Royal Melbourne Hospital, and the LICR Melbourne Centre, located at the Austin Hospital, are part of the world’s largest cancer research institute. LICR currently has ten branches in seven countries with an 11th site planned in Singapore. The non-profit Institute’s infrastructure allows it to patent research discoveries, and sponsor and conduct its own clinical trials in Europe, North America and Australasia, meaning that any research findings from the group can be translated rapidly into early-phase clinical trials. Professor Burgess is leading the ‘LICR Colon Cancer Initiative,’ the Institute’s international effort in CRC research.

For more information, please click here

Contacts:
Caroline Cody

61-039-341-3155

Copyright © Ludwig Institute for Cancer Research

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Sunblock poses potential hazard to sea life August 20th, 2014

Rice physicist emerges as leader in quantum materials research: Nevidomskyy wins both NSF CAREER Award and Cottrell Scholar Award August 20th, 2014

Graphene may be key to leap in supercapacitor performance August 20th, 2014

Newly-Developed Nanobiosensor Quickly Diagnoses Cancer August 20th, 2014

Govt.-Legislation/Regulation/Funding/Policy

Success in Intracellular Imaging of Cesium Distribution in Plants Used for Cesium Absorption August 19th, 2014

Electrical engineers take major step toward photonic circuits: Team invents non-metallic metamaterial that enables them to 'compress' and contain light August 19th, 2014

Promising Ferroelectric Materials Suffer From Unexpected Electric Polarizations: Brookhaven Lab scientists find surprising locked charge polarizations that impede performance in next-gen materials that could otherwise revolutionize data-driven devices August 18th, 2014

Novel chip-based platform could simplify measurements of single molecules: A nanopore-gated optofluidic chip combines electrical and optical measurements of single molecules onto a single platform August 14th, 2014

Nanomedicine

Newly-Developed Nanobiosensor Quickly Diagnoses Cancer August 20th, 2014

Graphene rubber bands could stretch limits of current healthcare, new research finds August 19th, 2014

Interaction between Drug, DNA for Designing Anticancer Drugs Studied in Iran August 17th, 2014

Iranian Scientists Stabilize Protein on Highly Stable Electrode Surface August 14th, 2014

Announcements

Rice physicist emerges as leader in quantum materials research: Nevidomskyy wins both NSF CAREER Award and Cottrell Scholar Award August 20th, 2014

Graphene may be key to leap in supercapacitor performance August 20th, 2014

Newly-Developed Nanobiosensor Quickly Diagnoses Cancer August 20th, 2014

Ultrasonic Waves Applied in Production of Graphene Nanosheets August 20th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Rice physicist emerges as leader in quantum materials research: Nevidomskyy wins both NSF CAREER Award and Cottrell Scholar Award August 20th, 2014

Oxford Instruments Asylum Research Receives the 2014 Microscopy Today Innovation Award for blueDrive Photothermal Excitation August 18th, 2014

AQUANOVA receives Technology Leadership Award 2014 FROST & SULLIVAN honors NovaSOL® Technology again August 12th, 2014

Focal blood-brain-barrier disruption with high-frequency pulsed electric fields August 12th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE